TD Asset Management
CGEM icon

TD Asset Management’s Cullinan Oncology CGEM Stock Holding History

TD Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
80,628
-33,772
-30% -$502K ﹤0.01% 1029
2026
Q1 		$1.63M Buy
+114,400
New +$1.47M ﹤0.01% 1011
2021
Q2 		– Sell
-18,739
Closed -$781K – 1526
2021
Q1 		$781K Buy
+18,739
New +$761K ﹤0.01% 1310

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TD Asset Management's CGEM Position: Q2 2026 in Review

TD Asset Management reduced its Cullinan Oncology (CGEM) stake by 30% in Q2 2026, selling an estimated $502K and leaving 80,628 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

TD Asset Management first reported a position in CGEM in Q1 2021 and has held it in 3 quarters since. The position peaked at $1.63M in Q1 2026. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • TD Asset Management held 80,628 shares of Cullinan Oncology worth $1.47M as of Q2 2026.
  • TD Asset Management sold 33,772 Cullinan Oncology shares in Q2 2026, an estimated $502K.
  • Cullinan Oncology made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1029 holding.
  • TD Asset Management first reported a position in Cullinan Oncology in Q1 2021 and has held it in 3 quarters since.
  • TD Asset Management's Cullinan Oncology position peaked at $1.63M in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.